Efficacy outcomes included composite kidney (kidney failure, a sustained 57% decrease in eGFR from baseline over at least 4 weeks or kidney-related death) and CV (CV death, non-fatal myocardial infarction, non-fatal stroke or hospitalisation for heart failure) outcomes
More specifically, the researchers posited that the peptide may have enhanced the expression of Ki-67 and CD98hc that are less intensively synthesized during cell aging. Epithalon also seemed to inhibit the activity of Caspase-3, a crucial enzyme believed to facilitate apoptosis (programmed cell death)
However, patients might notice a decrease in effectiveness as their weekly levels drop
By doing so, it becomes effective protection against obesity and insulin resistance that stems from the diet that one is taking or age
Existing cost-shares for diabetes-related prescriptions remain unchanged
Specific issues with the Dihexa compound (synthesis, stability, pharmacokinetics in humans) may have created technical hurdles